<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">

Webinar: Chemotherapy-induced Pain

 

Chemotherapy-induced Peripheral Pain (CIPN)

 

Evaluating the neuroprotective effects of pain therapies following chemotherapy treatment. 

 

Chemotherapy treatments frequently result in painful neuropathies and neurotoxicity. Chemotherapy-induced neuropathy tends to progress during treatment and generally resides once treatment stops. It is estimated, however, that in 30% of cases it may persist up to 6 months after chemotherapy treatment has finished. Symptoms include motor and sensory, can be prolonged and severe, and is difficult to treat.

In this webinar, we discuss in vivo and in vitro models for assessing the underlying mechanisms of CIPN and the neuroprotective effects of compounds. 

 

READY TO DISCUSS YOUR PROGRAM?

If you are ready to discuss how a partnership can fit into your development program, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can rely on predictive preclinical data.

Request Proposal